US FDA Approves Production of World's First Cancer Vaccine within Months

The US Food and Drug Administration (FDA) has granted the world's first cancer vaccine, which is produced by Moderna, the title of "breakthrough" for the prevention of skin cancer.

The decision made by the FDA means that it can be approved within months, bringing the vaccine one step closer to reality.

According to the British Daily Mail, the vaccine reduces the risk of skin cancer recurrence or death by 44%, noting that Moderna is communicating with the US Food and Drug Administration to review priority data.

And the newspaper said that the second phase trial showed that the vaccine reduces the chance of relapse or death in patients after surgery by 44%, compared to the immunotherapy drug alone.

More than a million Americans suffer from melanoma, the deadliest form of skin cancer.